MMP9 and renal cell carcinoma: Recent anoikis-based RCC risk prediction models by Zhuo Chen and Jin Wang represent progress in this direction, though they still require robust experimental validation [49,66]—a gap our current ARGs and MMP9’s experimental findings help address.